Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49

1.

Identification and characterization of novel and potent transcription promoters of Francisella tularensis.

Zaide G, Grosfeld H, Ehrlich S, Zvi A, Cohen O, Shafferman A.

Appl Environ Microbiol. 2011 Mar;77(5):1608-18. doi: 10.1128/AEM.01862-10. Epub 2010 Dec 30.

2.

Novel and unique diagnostic biomarkers for Bacillus anthracis infection.

Sela-Abramovich S, Chitlaru T, Gat O, Grosfeld H, Cohen O, Shafferman A.

Appl Environ Microbiol. 2009 Oct;75(19):6157-67. doi: 10.1128/AEM.00766-09. Epub 2009 Jul 31.

3.

Characterization of Bacillus anthracis iron-regulated surface determinant (Isd) proteins containing NEAT domains.

Gat O, Zaide G, Inbar I, Grosfeld H, Chitlaru T, Levy H, Shafferman A.

Mol Microbiol. 2008 Nov;70(4):983-99. doi: 10.1111/j.1365-2958.2008.06460.x. Epub 2008 Sep 30.

5.

Identification of in vivo-expressed immunogenic proteins by serological proteome analysis of the Bacillus anthracis secretome.

Chitlaru T, Gat O, Grosfeld H, Inbar I, Gozlan Y, Shafferman A.

Infect Immun. 2007 Jun;75(6):2841-52. Epub 2007 Mar 12.

6.

Search for Bacillus anthracis potential vaccine candidates by a functional genomic-serologic screen.

Gat O, Grosfeld H, Ariel N, Inbar I, Zaide G, Broder Y, Zvi A, Chitlaru T, Altboum Z, Stein D, Cohen S, Shafferman A.

Infect Immun. 2006 Jul;74(7):3987-4001.

7.

The solute-binding component of a putative Mn(II) ABC transporter (MntA) is a novel Bacillus anthracis virulence determinant.

Gat O, Mendelson I, Chitlaru T, Ariel N, Altboum Z, Levy H, Weiss S, Grosfeld H, Cohen S, Shafferman A.

Mol Microbiol. 2005 Oct;58(2):533-51.

8.

Vaccination with plasmid DNA expressing the Yersinia pestis capsular protein F1 protects mice against plague.

Grosfeld H, Bino T, Flashner Y, Ber R, Mamroud E, Lustig S, Velan B, Shafferman A, Cohen S.

Adv Exp Med Biol. 2003;529:423-4. No abstract available.

PMID:
12756802
9.

Effective protective immunity to Yersinia pestis infection conferred by DNA vaccine coding for derivatives of the F1 capsular antigen.

Grosfeld H, Cohen S, Bino T, Flashner Y, Ber R, Mamroud E, Kronman C, Shafferman A, Velan B.

Infect Immun. 2003 Jan;71(1):374-83.

10.

Search for potential vaccine candidate open reading frames in the Bacillus anthracis virulence plasmid pXO1: in silico and in vitro screening.

Ariel N, Zvi A, Grosfeld H, Gat O, Inbar Y, Velan B, Cohen S, Shafferman A.

Infect Immun. 2002 Dec;70(12):6817-27.

11.

Pressure and heat inactivation of recombinant human acetylcholinesterase. Importance of residue E202 for enzyme stability.

Cléry-Barraud C, Ordentlich A, Grosfeld H, Shafferman A, Masson P.

Eur J Biochem. 2002 Sep;269(17):4297-307.

13.

Interactions of oxime reactivators with diethylphosphoryl adducts of human acetylcholinesterase and its mutant derivatives.

Grosfeld H, Barak D, Ordentlich A, Velan B, Shafferman A.

Mol Pharmacol. 1996 Sep;50(3):639-49.

PMID:
8794905
14.

Transcription elongation factor of respiratory syncytial virus, a nonsegmented negative-strand RNA virus.

Collins PL, Hill MG, Cristina J, Grosfeld H.

Proc Natl Acad Sci U S A. 1996 Jan 9;93(1):81-5.

15.

Alphavirus hybrid virion vaccines.

Shafferman A, Lustig S, Inbar Y, Halevy M, Schneider P, Bino T, Leitner M, Grosfeld H, Velan B, Schödel F, Cohen S.

Adv Exp Med Biol. 1996;397:41-7. No abstract available.

PMID:
8718580
18.

Rescue of a 7502-nucleotide (49.3% of full-length) synthetic analog of respiratory syncytial virus genomic RNA.

Collins PL, Mink MA, Hill MG 3rd, Camargo E, Grosfeld H, Stec DS.

Virology. 1993 Jul;195(1):252-6.

PMID:
8317100
19.

Production and secretion of high levels of recombinant human acetylcholinesterase in cultured cell lines: microheterogeneity of the catalytic subunit.

Kronman C, Velan B, Gozes Y, Leitner M, Flashner Y, Lazar A, Marcus D, Sery T, Papier Y, Grosfeld H, et al.

Gene. 1992 Nov 16;121(2):295-304.

PMID:
1446827
20.

Substrate inhibition of acetylcholinesterase: residues affecting signal transduction from the surface to the catalytic center.

Shafferman A, Velan B, Ordentlich A, Kronman C, Grosfeld H, Leitner M, Flashner Y, Cohen S, Barak D, Ariel N.

EMBO J. 1992 Oct;11(10):3561-8.

21.

Mutagenesis of human acetylcholinesterase. Identification of residues involved in catalytic activity and in polypeptide folding.

Shafferman A, Kronman C, Flashner Y, Leitner M, Grosfeld H, Ordentlich A, Gozes Y, Cohen S, Ariel N, Barak D, et al.

J Biol Chem. 1992 Sep 5;267(25):17640-8.

22.

Divergent envelope E2 alphavirus sequences spanning amino acids 297 to 352 induce in mice virus-specific protective immunity and antibodies with complement-mediated cytolytic activity.

Grosfeld H, Lustig S, Gozes Y, Velan B, Cohen S, Leitner M, Lachmi B, Katz D, Olshevski U, Shafferman A.

J Virol. 1992 Feb;66(2):1084-90.

23.

The effect of elimination of intersubunit disulfide bonds on the activity, assembly, and secretion of recombinant human acetylcholinesterase. Expression of acetylcholinesterase Cys-580----Ala mutant.

Velan B, Grosfeld H, Kronman C, Leitner M, Gozes Y, Lazar A, Flashner Y, Marcus D, Cohen S, Shafferman A.

J Biol Chem. 1991 Dec 15;266(35):23977-84.

24.

Delineation of protective epitopes on the E2-envelope glycoprotein of Semliki Forest virus.

Grosfeld H, Velan B, Leitner M, Lustig S, Lachi BE, Cohen S, Shafferman A.

Vaccine. 1991 Jun;9(6):451-6.

PMID:
1716035
25.

Recombinant human acetylcholinesterase is secreted from transiently transfected 293 cells as a soluble globular enzyme.

Velan B, Kronman C, Grosfeld H, Leitner M, Gozes Y, Flashner Y, Sery T, Cohen S, Ben-Aziz R, Seidman S, et al.

Cell Mol Neurobiol. 1991 Feb;11(1):143-56.

PMID:
1849451
26.

Serologically defined linear epitopes in the E2 envelope glycoprotein of Semliki Forest virus.

Ariel N, Lehrer S, Elhanaty E, Sabo T, Brodt P, Lachmi B, Katz D, Levin R, Grosfeld H, Velan B, et al.

Arch Virol. 1990;113(1-2):99-106.

PMID:
1696808
27.

Semliki Forest virus E2 envelope epitopes induce a nonneutralizing humoral response which protects mice against lethal challenge.

Grosfeld H, Velan B, Leitner M, Cohen S, Lustig S, Lachmi BE, Shafferman A.

J Virol. 1989 Aug;63(8):3416-22.

28.

Production of monoclonal antibodies toward bovine interferons-alpha suitable for immunopurification.

Kobiler D, Grosfeld H, Leitner M, Monzain R, Frist C, Seri T, Cohen S, Velan B, Shafferman A, Gozes Y.

J Interferon Res. 1989 Apr;9(2):189-93.

PMID:
2715671
29.

Patterns of antibody recognition of selected conserved amino acid sequences from the HIV envelope in sera from different stages of HIV infection.

Shafferman A, Lennox J, Grosfeld H, Sadoff J, Redfield RR, Burke DS.

AIDS Res Hum Retroviruses. 1989 Feb;5(1):33-9.

PMID:
2541748
31.

Isolation of bovine IFN-alpha genes and their expression in bacteria.

Velan B, Cohen S, Grosfeld H, Shafferman A.

Methods Enzymol. 1986;119:464-74. No abstract available.

PMID:
3020355
32.

Bovine interferon alpha genes. Structure and expression.

Velan B, Cohen S, Grosfeld H, Leitner M, Shafferman A.

J Biol Chem. 1985 May 10;260(9):5498-504.

33.

Genetic engineering of human interferons from lymphoblastoid cells: III. Purification, physicochemical and biological properties of bacterial IFN-alpha J1.

Grosfeld H, Cohen S, Velan B, Shafferman A.

Adv Biotechnol Processes. 1985;4:59-78. No abstract available.

PMID:
3902054
34.

Genetic engineering of human interferons from lymphoblastoid cells: II. Construction of trp expression plasmids and their use for efficient expression of IFN-alpha J1.

Shafferman A, Cohen S, Grosfeld H, Leitner M, Velan B.

Adv Biotechnol Processes. 1985;4:25-57. Review. No abstract available.

PMID:
3902052
35.

Cloning of a bovine interferon-alpha gene subfamily and comparisons between genetically engineered and leukocyte bovine interferons.

Velan B, Cohen S, Grosfeld H, Shalita Z, Shafferman A.

Dev Biol Stand. 1985;60:355-69.

PMID:
3899795
36.

Cloning, expression and biological activity of a new variant of human interferon alpha identified in virus induced lymphoblastoid cells.

Cohen S, Velan B, Grosfeld H, Shalita Z, Leitner M, Shafferman A.

Dev Biol Stand. 1985;60:111-22.

PMID:
2995168
37.

Mutations not altering the symmetrical sequences in the trp operator yield a constitutive phenotype.

Grosfeld H, Cohen S, Velan B, Shalita Z, Shafferman A.

Mol Gen Genet. 1984;195(1-2):358-60.

PMID:
6092859
38.

Human lymphoblastoid interferon for clinical trials: large scale purification and safety tests.

Lazar A, Marcus D, Reuveny S, Grosfeld H, Traub A, Feinstein S, Mizrahi A.

Dev Biol Stand. 1983;55:231-8.

PMID:
6677533
39.

Role of phosphorylation-dephosphorylation cycles in the control of protein synthesis in eukaryotes.

Ochoa S, de Haro C, Siekierka J, Grosfeld H.

Curr Top Cell Regul. 1981;18:421-35. No abstract available.

PMID:
7273848
40.

Isolation of two species of human lymphoblastoid (Namalva) cell-derived interferon that differ in rates of clearance, size, and cell specificity.

Traub A, Feinstein S, Grosfeld H, Payess B, Lazar A, Reuveny S, Mizrahi A.

J Interferon Res. 1981;1(4):571-9.

PMID:
6180089
41.

Factors affecting the large scale production of human lymphoblastoid interferon.

Lazar A, Reuveny S, Traub A, Minai M, Grosfeld H, Feinstein S, Gez M, Mizrahi A.

Dev Biol Stand. 1981;50:167-71.

PMID:
6176484
43.
44.

5'-Capping structures of Artemia salina mRNA and the translational inhibition by cap analogs.

Groner Y, Grosfeld H, Littauer UZ.

Eur J Biochem. 1976 Dec;71(1):281-93.

45.

The translation in vitro of mRNA from developing cysts of Artemia salina.

Grosfeld H, Littauer UZ.

Eur J Biochem. 1976 Nov 15;70(2):589-99.

46.

Large subunit ribulosebisphosphate carboxylase messenger RNA from Euglena chloroplasts.

Sagher D, Grosfeld H, Edelman M.

Proc Natl Acad Sci U S A. 1976 Mar;73(3):722-6.

47.

Cryptic form of mRNA in dormant Artemia salina cysts.

Grosfeld H, Littauer UZ.

Biochem Biophys Res Commun. 1975 Nov 3;67(1):176-81. No abstract available.

PMID:
1201017
48.

Proceedings: In vitro translation of mRNA from developing cysts of Artemia salina.

Grosfeld H, Littauer UZ.

Isr J Med Sci. 1975 Nov;11(11):1203-4. No abstract available.

PMID:
1205794
49.

Stepwise phosphorolysis with polynucleotide phosphorylase: a novel method for sequence analysis of oligoribonucleotides.

Kaufmann G, Grosfeld H, Littauer UZ.

FEBS Lett. 1973 Apr 1;31(1):47-52. No abstract available.

Supplemental Content

Loading ...
Support Center